European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer

Following two Delphi rounds and expert panel discussions, the European Association of Nuclear Medicine Focus 5 meeting reached consensus for key statements regarding the role of advanced imaging techniques in prostate cancer. It also contoured the place of theranostics in relation to the classical approach of conservative hormonal therapies or chemotherapies.